You searched for "ESCRS"

361 results found

Envision Glasses – a different take on a sight impairment wearable (part 1)

In recent issues we reviewed the OrCam MyEye Pro, a glasses mounted mobile device that can assist sight impaired users. This time we are taking a look at the Envision Glasses, a comparable device that takes a different approach (see...

Empatheyes

For Dec/Jan 2024 we are showcasing a remarkably well-named technological solution. Empatheyes provides a unique way for people to increase their understanding of the experience of having a sight disorder. Whether for parents of children with sight disorders, corporate awareness...

Scottish Government announces permanent free rail travel for companions of visually impaired people

Sight Scotland and Sight Scotland Veterans welcome the Scottish Government announcement today that free rail travel for companions of visually impaired people has been made a permanent policy across all ScotRail and Caledonian Sleeper services. Sight Scotland and Sight Scotland...

The Rapid Assessment of Avoidable Blindness: How ICEH maintains the cornerstone of global eye health data

In this paper we will discuss The Rapid Assessment of Avoidable Blindness (RAAB), a survey methodology that has become the single largest source of population eye health data globally. The origins of RAAB The RAAB is a rapid, population-based survey...

Specialty-driven EMR for paperless clinical environment – insights for an informed choice

Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...

Semaglutide and vision loss: A new concern for NAION risk?

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

DR-NET National DR Workshop in Tanzania: Policy, training and technology

Diabetic retinopathy (DR) is a leading cause of moderate to severe visual impairment (VI) and blindness worldwide, posing a significant public health challenge. As the prevalence of diabetes continues to rise globally, particularly in low- and middle-income countries (LMICs), the...

SOS (Simplified Ophthalmic Statistics) Part 2: How to summarise your data and why it’s a good idea to do so

Studies involve capturing data. Statistical techniques allow data to be used to answer important research questions. A case series may have data on a handful of subjects but we are now entering the Big Data arena where datasets can be...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...

My experience of the transition into a specialist orthoptist role

Michelle Dent discusses the process of transitioning into a new role and the pros and cons along the way. An opportunity arose for a permanent, full time, band 7 specialist role in the medical retina (MR) team in the Newcastle...

Principles of management

Whatever section of pathology is to blame and wherever it strikes, the aim of treatment is always the same. Find the cause if you can. Establish the effects of the cause. Halt the pathological process if you can. Reverse its...

Farnborough International Airshow 2022 partners with Orbis UK

Farnborough International Airshow (FIA) announces Orbis UK as its official charity partner for 2022.